Skip to search boxSkip to navigationSkip to main content

TIMP-1 Inhibits apoptosis in lung adenocarcinoma cells via interaction with Bcl-2

  • Srilatha Nalluri
    ,
  • Sampa Ghoshal-Gupta
    ,
  • Ammar Kutiyanawalla
    ,
  • Sitaram Gayatri
    ,
  • Byung Rho Lee
    ,
  • Shahanawaz Jiwani
Scholary Output:
Contribution to journal
Article
Research
Peer-review

Open access

Sustainable Development Goals

  • SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well

Abstract

<p>Tissue inhibitors of metalloproteinases (TIMPs) are multifaceted molecules that exhibit properties beyond their classical proteinase inhibitory function. Although TIMP-1 is a known inhibitor of apoptosis in mammalian cells, the mechanisms by which it exerts its effects are not well-established. Our earlier studies using H2009 lung adenocarcinoma cells, implanted in the CNS, showed that TIMP-1 overexpressing H2009 cells (HB-1), resulted in more aggressive tumor kinetics and increased vasculature. The present study was undertaken to elucidate the role of TIMP-1 in the context of apoptosis, using the same lung cancer cell lines. Overexpressing TIMP-1 in a lung adenocarcinoma cell line H2009 resulted in an approximately 3-fold increased expression of Bcl-2, with a marked reduction in apoptosis upon staurosporine treatment. This was an MMP-independent function as a clone expressing TIMP-1 mutant T2G, lacking MMP inhibition activity, inhibited apoptosis as strongly as TIMP1 overexpressing clones, as determined by inhibition of PARP cleavage. Immunoprecipitation of Bcl-2 from cell lysates also co-immunoprecipitated TIMP-1, indicative of an interaction between these two proteins. This interaction was specific for TIMP-1 as TIMP-2 was not present in the Bcl-2 pull-down. Additionally, we show a co-dependency of TIMP-1 and Bcl-2 RNA and protein levels, such that abrogating Bcl-2 causes a downregulation of TIMP-1 but not TIMP-2. Finally, we demonstrate that TIMP-1 dependent inhibition of apoptosis occurs through p90RSK, with phosphorylation of the pro-apoptotic protein BAD at serine 112, ultimately reducing Bax levels and increasing mitochondrial permeability. Together, these studies define TIMP-1 as an important cancer biomarker and demonstrate the potential TIMP-1 as a crucial therapeutic target.</p>

Publication Information

Output type

Scholary Output:
Contribution to journal
Article
Research
Peer-review

Original language

English (US)

Article number

e0137673

Journal (Volume, Issue Number)

PloS one (Volume 10, Issue 9)

Publication milestones

  • Published - 09/14/2015

Publication status

Published - 09/14/2015

ISSN

1932-6203

Publication IDs

  • Scopus: 84947546483
  • PubMed: 26366732

Publication metrics

Metrics

Scopus
citations
SciVal
citations
24
SciVal
FWCI
1.18
SciVal
Author count
8
SciVal
Paper percentile
86
Fractional count
2
Fractional count
0.25
Fractional count
6
Fractional count
0.75
Fractional count
2
Fractional count
1

PlumX, opens in new tab

Citation count
41
Captures
40